Table 1: Patient characteristics.
| Patient Characteristics | Adults (n = 15) | Adolescents (n = 18) |
| Mean age (range) | 38.2 (19-61) | 14.89 (11-17) |
| Gender | Females: 9 (60%) | Females: 7 (39%) |
Marital status |
Married/Partnership: 9 (60%) Single: 5 (33%) Widowed: 1 (7%) |
Not reported |
Highest educational level |
Part of secondary school: 1 (7%) Finished secondary school: 5 (33%) Vocational/College: 3 (20%) Undergraduate degree: 4 (27%) Postgraduate degree: 2 (13%) |
Part of secondary school: 18 (100%) |
Employment status |
Employed full time: 5 (33%) Employed part time: 6 (40%) Self-employed: 1 (7%) student: 2 (13%) Retired: 1 (7%) |
Student: 18 (100%) |
Time since GRAZAX® finished |
Mean 9.7 months (2 months - 24 months) | Mean 6.4 months (1 month - 18 months) |
| Medication taken before GRAZAX® | ||
| Anti-histamines | 47% (n = 7) | 22% (n = 4) |
| Nose spray (not specified) | 33% (n = 5) | 22% (n = 4) |
| Eye drops (not specified) | 33% (n = 5) | 11% (n = 2) |
| Inhaler (salbutamol or other) | 13% (n = 2) | 11% (n = 2) |
| Skin creams | 0% (n = 0) | 5.5% (n = 1) |
| Tablets (not specified) | 0% (n = 0) | 5.5% (n = 1) |
| Cortisone tablets | 7% (n = 1) | 0% (n = 0) |
| Homeopathy | 7% (n = 1) | 0% (n = 0) |
| Throat sweets | 7% (n = 1) | 0% (n = 0) |